NZ’s new medicines fast-track promises quicker approvals. But what about access?
A surge in severe respiratory illness has been placing New Zealand’s hospitals under intense pressure over recent weeks.…
Bridge to Fit: Before you start GLP-1 medications, read this
Now, I’m not a doctor, so I’m not recommending or not recommending weight loss drugs, period. That’s a…
New pancreatic cancer drug offers hope but raises access questions with a hefty price tag
A newly approved pancreatic cancer drug is offering new hope for some patients, but its nearly half-million-dollar price…
Epinephrine injections recalled over sterility concerns
FDA announces nationwide recall of epinephrine injections over sterility and particulate concerns A nationwide voluntary recall of three…
Party Drug MDMA Approved By New Zealand To Treat Trauma
Two psychiatrists in New Zealand won approval Friday to prescribe pharmaceutical-grade MDMA to sufferers of severe post-traumatic stress…
How GLP-1-Taking Dietitians Are Changing the Medication’s Stigma
10 min read Something strange started happening to Gianna Beasley four years ago. Despite doing everything right with…
‘Blockbuster’ reatrutide is coming. Will it help Louisiana? | Louisiana Health
A new obesity medication is coming, one that may prove a “blockbuster” in states like Louisiana that struggle with…
Epinephrine injections recalled over sterility concerns
FDA announces nationwide recall of epinephrine injections over sterility and particulate concerns A nationwide voluntary recall of three…
Ocular Therapeutix (OCUL): Faster Path To Approval Comes With Rising Costs
On August 3, Ocular Therapeutix (NASDAQ:OCUL) reported second-quarter 2026 financial results that read as much like a regulatory…
Hack of the day: How to find your nearest Jan Aushadhi store
Affordable healthcare is a pressing concern for millions of patients across India. Government-supported Jan Aushadhi stores provide generic…
FDA tracking hundreds of reports tied to compounded weight-loss drugs, unapproved peptides
(WBAY) – The FDA is tracking hundreds of reported problems involving compounded weight-loss medications, as unapproved peptide products…
GLP-1 Scripts Rising Faster Among Adults With Serious Mental Illness
People with serious mental illness (SMI) face high cardiovascular risk, making GLP-1 drugs a potential tool to reduce…